A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, Largo, Florida, United States

Research Site, Fort Wayne, Indiana, United States

Research Site, Omaha, Nebraska, United States

Research Site, New York, New York, United States

Research Site, Houston, Texas, United States

Research Site, Puyallup, Washington, United States

Research Site, Beijing, China

Research Site, Changsha, China

Research Site, Guangzhou, China

Research Site, Linyi, China

Research Site, Shandong, China

Research Site, Wuhan, China

Research Site, Zhengzhou, China

Research Site, Clermont-Ferrand, France

Research Site, La Roche-sur-Yon, France

Research Site, Montpellier, France

Research Site, Paris, France

Research Site, Pierre-Bénite, France

Research Site, Aviano, Italy

Research Site, Florence, Italy

Research Site, Meldola, Italy

Research Site, Milan, Italy

Research Site, Naples, Italy

Research Site, Roma, Italy

Research Site, Bukgu, South Korea

Research Site, Goyang-si, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, Seoul, South Korea

Research Site, A Coruña, Spain

Research Site, Barcelona, Spain

Research Site, Granada, Spain

Research Site, Madrid, Spain

Research Site, Madrid, Spain

Research Site, Seville, Spain

Research Site, Valencia, Spain